Sertal Compound: Uses, Presentation, Dosage, Interactions, Side Effects, Contraindications and Storage

It is the association of propinox hydrochloride and lysine clonixinate.

Compound sertal is an analgesic and antispasmodic drug indicated to treat pain and spasm of smooth muscle, located in any part of the digestive, genital, urinary and hepatovesicular tracts.

Presentation of composite sertal

This medicine has:

  • An oral presentation: coated tablets.
  • An intramuscular or intravenous presentation : injectable solution.

The active substance in the compound sertal is propinox (pargeverine) and lysine clonixinate.

Compound sertal dosage

Common dosages are generally:

Adults and children over 12 years: 1 coated tablet 3 to 4 times a day. The coated tablets should be swallowed whole, without chewing and with plenty of fluids.

This medicine must be administered under the strict prescription of the doctor. Don’t self-medicate.

Compound signal interactions

The following are just a few interactions; so these are not all drugs that interact with the compound sertal.

  • Alcohol : The use of alcohol after ingestion of ibuprofen may increase the risk of an additive effect of upper gastrointestinal bleeding in the damage of the gastric mucosa. Avoid drinking alcohol within 12 hours of taking this drug.
  • Alendronate : The use of alendronate may increase the gastrointestinal adverse effects of ibuprofen.
  • Aminoglycosides : concomitant use can increase the nephrotoxic effects of aminoglycosides and NSAIDs can reduce their renal excretion. It is suggested to monitor renal function during co-administration.
  • Oral anticoagulants : The use of oral anticoagulants may increase the risk of bleeding due to the displacement of protein-binding anticoagulants.
  • Aspirin: The use of ibuprofen with aspirin may decrease the effectiveness of the latter for platelet aggregation due to competition for the binding of the cyclooxygenase site.
  • Cyclosporine: the use of an NSAID with cyclosporine may increase the concentrations of the latter and increase the risk of renal toxicity. Measure cyclosporine in the blood and monitor kidney function and adjust the dose.
  • Clopidogrel : Concurrent administration with clopidogrel may increase the risk of gastrointestinal bleeding due to the antiplatelet effect of the latter. Look for signs or symptoms of gastrointestinal bleeding.
  • Levofloxacin: The use of an NSAID and levofloxacin may increase the risk of seizures in patients with a history of epilepsy or seizures by inhibiting the action of gamma-aminobutyric acid (GABA) centrally.
  • Pemetrexed: Concomitant use of these drugs increases the toxicity of pemetrexed (myelosuppression, nephrotoxicity, gastrointestinal toxicity) and that NSAIDs interfere with renal excretion.
  • Sulfonylureas: The use of sulfonylureas with an NSAID may increase the risk of hypoglycemia possibly due to inhibition of metabolism and protein binding competition. This effect is seen more often with first-generation sulfonylureas (chlorpropramide, tolbutamide, glibenclamide).
  • Tacrine : the use of NSAIDs can increase the hepatotoxic effect of tacrine. Avoid association, otherwise monitor liver function during combination therapy.
  • Tacrolimus : The use of an NSAID with tacrolimus can lead to renal failure, probably by inhibiting the production of renal vasodilator prostaglandins. Avoid this association or do not control kidney function.
  • Valerian : joint use increases the risk of hepatotoxicity. Avoid co-administration, otherwise monitor liver function.

Side effects of compound sertal

The following are some effects derived from the use of Compound Sertal:

  • Arterial insufficiency generally of the Raynaud’s type, bradycardia, CHF, edema, hypotension , intensification of AV block.
  • Dizziness
  • Fatigue.
  • Alopecia.
  • Erythema multiforme.
  • Exfoliative dermatitis.
  • Psoriasiform eruptions.
  • Stevens-Johnson syndrome.
  • Toxic epidermal necrolysis.
  • Urticaria.
  • Dry eyes, visual disturbances.
  • Abdominal cramps, constipation, diarrhea, epigastric distress, ischemic colitis.
  • Trombosis arterial mesentérica.
  • Sickness.
  • Vomiting
  • Impotence.
  • Agranulocytosis, non-thrombocytopenic and thrombocytopenic purpura.
  • Hypersensitivity
  • Agranulocytosis, anaphylactic / anaphylactoid reactions,
  • Fever combined with malaise and sore throat, laryngospasm, pharyngitis, respiratory distress.
  • Bronchospasm, shortness of breath, dyspnea, wheezing.
  • Peyronie’s disease, SLE-like reactions, systemic lupus erythematosus.

Side effects may vary depending on the condition and other factors inherent to the patient such as:
age, health or other underlying diseases.

Contraindications

Compound sertal is contraindicated in the following cases:

  • It should not be administered during pregnancy and lactation.
  • It is contraindicated in cases of peptic ulcer or gastrointestinal bleeding.
  • Use with caution in cases of coronary artery disease, peripheral vascular disease, severe hypertension, liver or kidney failure.

Storage

The compound must be kept out of the reach of children and must be kept in an environment free from humidity and heat.